Synopsis
ICD Researchs AstraZeneca PLC: Pharmaceuticals and Healthcare Company Profile,
SWOT & Financial Report contains in depth information and data about the company
and its operations. The profile contains a company overview, business
description, competitive benchmarking, SWOT analysis, key facts, information on
products and services, details of locations and subsidiaries, plus information
on key news events affecting the company.
Summary
ICD Researchs AstraZeneca PLC: Pharmaceuticals and Healthcare Company Profile,
SWOT & Financial Report is a crucial resource for industry executives and anyone
looking to access key information about AstraZeneca PLC.
ICD Researchs AstraZeneca PLC: Pharmaceuticals and Healthcare Company Profile,
SWOT & Financial Report report utilizes a wide range of primary and secondary
sources, which are analyzed and presented in a consistent and easily accessible
format. ICD Research strictly follows a standardized research methodology to
ensure high levels of data quality and these characteristics guarantee a unique
report.
Scope
• Examines and identifies key information and issues about AstraZeneca PLC for
business intelligence requirements.
• Studies and presents the companys strengths, weaknesses, opportunities
(growth potential) and threats (competition). Strategic and operational business
information is objectively reported.
• Provides data on company financial performance and competitive benchmarking.
• The profile also contains information on business operations, company history,
major products and services, prospects, key employees, locations and
subsidiaries.
Reasons To Buy
• Quickly enhance your understanding of AstraZeneca PLC.
• Gain insight into the marketplace and a better understanding of internal and
external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’
businesses better.
• Recognize potential partnerships and suppliers.
Key Highlights
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company. The company
discovers, develops, produces and markets a broad range of biologics,
prescription pharmaceuticals and vaccines for the treatment of diseases such as
cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory
and inflammation. AstraZenecas research and development activities are focused
on the development of implants and medical devices with principle focus on type
2 diabetes, infections, COPD, cancer, Alzheimers diseases and other areas. The
company has presence in more than 100 countries throughout the world. It has 14
research and development sites in eight countries and 23 manufacturing plants in
16 countries. AstraZeneca is headquartered in London, the UK.